Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 12, Pages e0145666
Publisher
Public Library of Science (PLoS)
Online
2015-12-24
DOI
10.1371/journal.pone.0145666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Converging Indications of Aldosterone Antagonists (Spironolactone and Eplerenone): A Narrative Review of Safety Profiles
- (2014) Mohammed I Danjuma et al. CURRENT HYPERTENSION REPORTS
- Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes
- (2014) Greg Tesch et al. DIABETOLOGIA
- Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease
- (2014) L. L. Huang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms
- (2013) Dong Chen et al. GENE
- PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
- (2013) Stephen Orena et al. Frontiers in Pharmacology
- Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
- (2012) H. Shibata et al. AMERICAN JOURNAL OF HYPERTENSION
- Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
- (2012) Lars Bärfacker et al. ChemMedChem
- Aldosterone Induces Kidney Fibroblast Proliferation via Activation of Growth Factor Receptors and PI3K/MAPK Signalling
- (2012) L.L. Huang et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Antihypertensive and Cardiorenal Protective Effects of SM-368229, a Novel Mineralocorticoid Receptor Antagonist, in Aldosterone/Salt-Treated Rats
- (2012) Tetsuro Nariai et al. PHARMACOLOGY
- Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
- (2011) Jean-Philippe Bertocchio et al. KIDNEY INTERNATIONAL
- Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease
- (2011) M. Lian et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
- (2011) Lene Boesby et al. PLoS One
- Intensive Versus Conventional Therapy to Slow the Progression of Idiopathic Glomerular Diseases
- (2010) Stefano Bianchi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats
- (2010) Nicole Schupp et al. FASEB JOURNAL
- A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
- (2010) Jérôme Fagart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells
- (2008) Suwarni Diah et al. EXPERIMENTAL CELL RESEARCH
- The role of aldosterone blockade in murine lupus nephritis
- (2008) Seetha U Monrad et al. ARTHRITIS RESEARCH & THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now